Back to search

Netherlands· NL-974d4e58f1a0

Acemap 20 mg tabletten

A penfluridol product containing penfluridol, registered in Netherlands by ACE Pharmaceuticals B.V.. The same ATC class is registered in 4 of our 19 countries.

ATC N05AG03

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedAcemap 20 mg tablettenATCN05AG03REGISTER NO.NL-974d4e58f1a0PACKS LISTED1CHECKEDSeptember 29, 2026

Where it is registered

Penfluridol is registered in 4 of 19 countries.

Countries holding a registration under ATC N05AG03 (penfluridol), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 2 of them publish a price we can compare per daily dose

Penfluridol · ATC N05AG03

4 / 19 countries

  • Finlandprice
  • Netherlands
  • Norwayprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
PENFLURIDOL
Manufacturer
ACE Pharmaceuticals B.V.
Country
Netherlands (NL)
ATC code
N05AG03
ATC class
Penfluridol
Defined daily dose
6 mg, O
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    129179

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Penfluridol in 2 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All penfluridol products

Authorised across Europe · EMA

The same active substance is authorised in 1 EEA country. Names it is sold under:

  • France · Acemap, Semap

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/428bf11a-e84d-4623-a87d-eb17e3d27740
GET /v1/drugs/428bf11a-e84d-4623-a87d-eb17e3d27740?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tablet",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h129179_smpc.pdf",
  "strength": null,
  "atc_label": "Penfluridol",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg129179",
  "excipients": [
    "CROSPOVIDON (E 1202)",
    "LACTOSE 1-WATER",
    "MAGNESIUMSTEARAAT (E 470b)",
    "MAÏSZETMEEL",
    "MAÏSZETMEEL, GEPREGELATINEERD",
    "SACCHAROSE"
  ],
  "substances": [
    "PENFLURIDOL"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h129179.pdf",
  "authorised_at": "2023/09/26",
  "procedure_number": "NL/H/5547/001",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "129179",
  "additional_monitoring": "N"
}

See everything about penfluridol.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.